Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $310.67 | $7.08 | 4,288.03% | 6,213.40x | 218.61x | 6.88x | 8.33x | 16.74x | $529.27M | 1.55% | $4.13B | 37.48 | $32.28B | 101.50 | ||
| CORT | CORCEPT THERAPEUTICS INC | $87.30 | $29.33 | 197.63% | 87.30x | 85.42x | 12.20x | 14.53x | 1.35x | $162.57M | 1.80% | $631.90M | 6.10 | $9.06B | 137.38 | ||
| NVO | NOVO NORDISK A S | $50.37 | $141.64 | -64.44% | 14.01x | 2.11x | 4.60x | 8.55x | 0.15x | $9.34B | 4.17% | $26.18B | 5.89 | $234.47B | 9.45 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $391.50 | $29.44 | 1,229.92% | 1,262.90x | 209.11x | 16.03x | 221.14x | 5.18x | $221.36M | 0.43% | $233.89M | 1.78 | $53.45B | 351.79 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.17 | $11.63 | -29.78% | 17.02x | 6.26x | 5.42x | 3.45x | 0.34x | -$23.64M | -5.18% | $133.17M | 2.38 | $468.23M | 6.97 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $41.55 | $14.80 | 180.68% | 84.80x | 41.64x | 5.19x | 5.88x | 1.27x | $101.73M | 3.28% | $535.38M | 7.17 | $2.98B | 55.70 | ||
| GMAB | GENMAB A | $31.57 | $108.15 | -70.81% | 13.47x | 1.75x | 5.69x | 3.52x | 0.12x | $1.19B | 5.89% | $5.75B | 8.96 | $18.65B | 9.32 | ||
| ARGX | ARGENX SE | $850.95 | $276.22 | 208.07% | 34.01x | 47.30x | 27,450.00x | 7.24x | 2.35x | $467.72M | 0.90% | $7.17B | 117.50 | $49.53B | 61.06 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $192.88 | $64.56 | 198.75% | 83.50x | 25.02x | 15.03x | 4.00x | 1.38x | $30.76M | 0.81% | $950.17M | 48.53 | $4.11B | 39.88 | ||
| VCEL | VERICEL CORP | $36.49 | $6.61 | 451.83% | 140.35x | 133.13x | 7.12x | 5.73x | 2.61x | $20.38M | 1.11% | $321.86M | 6.38 | $1.84B | 62.88 | ||
| TECH | BIO-TECHNE CORP | $58.69 | $16.30 | 260.04% | 117.38x | 29.03x | 7.50x | 4.65x | 1.60x | $224.06M | 2.46% | $1.97B | 12.65 | $9.39B | 42.53 | ||
| RPRX | ROYALTY PHARMA PLC | $38.53 | $42.17 | -8.64% | 21.89x | 8.01x | 7.08x | 2.31x | 0.44x | $2.11B | 12.69% | $9.62B | 22.28 | $30.25B | 28.97 | ||
| KRYS | KRYSTAL BIOTECH INC | $242.98 | $67.39 | 260.53% | 35.21x | 38.89x | 18.85x | 6.19x | 3.20x | $166.02M | 2.36% | $1.14B | 39.30 | $6.66B | 34.47 | ||
| VCYT | VERACYTE INC | $43.53 | $9.18 | 373.99% | 111.62x | 83.14x | 6.92x | 2.74x | 2.29x | $98.21M | 2.87% | $1.26B | 15.98 | $3.16B | 55.52 | ||
| CRMD | CORMEDIX INC | $11.33 | $13.19 | -14.09% | 4.99x | 4.53x | 4.01x | 2.39x | 25.96x | $74.42M | 8.65% | $374.13M | 4.93 | $993.11M | 8.85 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $15.69 | $7.71 | 103.51% | 27.05x | 20.67x | 7.78x | 5.66x | 1.31x | $119.87M | 5.79% | $365.77M | 2.78 | $2.07B | 20.03 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $52.12 | $41.68 | 25.03% | 19.16x | 17.62x | 3.23x | 1.65x | 0.73x | $832.13M | 8.31% | $6.06B | 31.54 | $9.36B | 12.11 | ||
| HALO | HALOZYME THERAPEUTICS INC | $63.45 | $74.85 | -15.23% | 12.98x | 9.91x | 5.98x | 14.81x | 0.50x | $602.40M | 8.10% | $503.92M | 4.30 | $8.55B | 10.12 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.74 | $1.30 | 34.25% | 24.86x | 68.77x | 2.23x | 2.64x | 0.71x | -$11.69M | -8.45% | $52.91M | 0.67 | $134.46M | 15.16 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.54 | $0.75 | 904.35% | 107.71x | 49.28x | 6.38x | 7.13x | 7.91x | $3.05M | 0.45% | $101.92M | 1.12 | $687.12M | 51.94 | ||
| EXEL | EXELIXIS INC | $41.38 | $29.06 | 42.38% | 16.82x | 16.00x | 4.85x | 5.13x | 1.01x | $779.77M | 7.02% | $2.16B | 8.05 | $10.89B | 11.74 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.92 | $36.68 | 6.10% | 12.05x | 11.94x | 2.71x | 2.68x | 0.79x | $296.89M | 13.26% | $835.12M | 14.51 | $1.76B | 6.54 | ||
| MNKD | MANNKIND CORP | $5.94 | $1.43 | 315.84% | 59.40x | 74.62x | 5.81x | -40.94x | 2.54x | $43.39M | 2.37% | -$44.55M | -0.15 | $2.06B | 28.10 | ||
| INCY | INCYTE CORP | $98.64 | $67.67 | 45.76% | 16.33x | 14.13x | 4.01x | 4.16x | 1.09x | $1.20B | 6.20% | $4.65B | 23.77 | $16.94B | 10.07 | ||
| INVA | INNOVIVA INC | $20.14 | $15.31 | 31.56% | 10.66x | 9.40x | 3.58x | 1.49x | 1.65x | $196.54M | 14.13% | $1.01B | 14.63 | $1.29B | 5.99 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $455.71 | $169.06 | 169.56% | 31.85x | 24.39x | 9.94x | 6.68x | 1.92x | $3.34B | 2.86% | $17.32B | 67.76 | $112.52B | 24.13 | ||
| ADMA | ADMA BIOLOGICS INC | $19.73 | $9.31 | 111.88% | 22.42x | 32.97x | 9.63x | 10.89x | 1.69x | $40.73M | 0.87% | $431.19M | 1.81 | $4.71B | 27.35 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.37 | $3.31 | 92.66% | 23.59x | 34.32x | 4.08x | 7.19x | 1.33x | $21.15M | 4.16% | $70.68M | 0.89 | $447.13M | 19.70 | ||
| UTHR | UNITED THERAPEUTICS CORP | $500.30 | $199.10 | 151.28% | 17.57x | 18.12x | 7.00x | 3.27x | 5.14x | $1.12B | 5.12% | $6.59B | 150.46 | $20.20B | 11.39 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $24.18 | $12.64 | 91.31% | 13.51x | 15.39x | 5.13x | 3.23x | 3.74x | $234.54M | 7.91% | $920.25M | 7.51 | $2.28B | 7.05 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $752.62 | $356.89 | 110.88% | 17.32x | 17.13x | 5.47x | 2.56x | 2.56x | $4.22B | 5.41% | $30.96B | 298.82 | $79.30B | 13.88 | ||
| MDXG | MIMEDX GROUP INC | $7.12 | $2.76 | 157.85% | 25.43x | 16.62x | 2.68x | 4.41x | 2.26x | $66.82M | 6.33% | $238.95M | 1.61 | $930.62M | 13.45 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.